Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-01-20 Purchase | 2023-01-24 4:30 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 1,923,076 | $13 | $24,999,988 | 11,609,704 (Indirect) | View |
2023-01-06 Purchase | 2023-01-10 5:14 pm | Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,853,000 | $2.21 | $4,095,130 | 6,144,881 (Indirect) | View |
2023-01-04 Purchase | 2023-01-06 4:39 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 180,703 | $7.2761 | $1,314,806 | 9,686,628 (Indirect) | View |
2023-01-03 Purchase | 2023-01-05 4:43 pm | IMARA Inc. | IMRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 629,297 | $3.9982 | $2,516,055 | 3,880,021 (Indirect) | View |
2022-12-27 Purchase | 2022-12-29 5:00 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 4,089 | $5.9941 | $24,510 | 9,505,925 (Indirect) | View |
2022-12-19 Purchase | 2022-12-21 4:30 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 98,787 | $5.8997 | $582,814 | 9,501,836 (Indirect) | View |
2022-12-14 Purchase | 2022-12-16 4:41 pm | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 2,403,049 | $5.4405 | $13,073,874 | 9,403,049 (Indirect) | View |
2022-12-08 Purchase | 2022-12-12 4:30 pm | IMARA Inc. | IMRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 29,899 | $3.8662 | $115,595 | 3,250,724 (Indirect) | View |
2022-11-17 Purchase | 2022-11-21 4:31 pm | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,389,500 | $12.5 | $42,368,750 | 426,302 (Indirect) | View |
2022-10-20 Purchase | 2022-10-24 4:41 pm | IMARA Inc. | IMRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 85,902 | $3.9209 | $336,812 | 3,220,825 (Indirect) | View |
2022-10-18 Purchase | 2022-10-20 5:28 pm | 89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,172,741 | $7.65 | $8,971,469 | 8,955,410 (Indirect) | View |
2022-10-17 Purchase | 2022-10-19 4:40 pm | IMARA Inc. | IMRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 506,197 | $3.6764 | $1,860,961 | 3,134,923 (Indirect) | View |
2022-10-17 Purchase | 2022-10-19 4:32 pm | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,640,000 | $36.5 | $59,860,000 | 6,848,911 (Indirect) | View |
2022-08-03 Purchase | 2022-08-05 4:06 pm | AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 1,909 | $7.5067 | $14,330 | 3,773,517 (Indirect) | View |
2022-07-26 Purchase | 2022-07-28 5:16 pm | AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 23,219 | $7.7813 | $180,675 | 3,771,608 (Indirect) | View |
2022-07-01 Purchase | 2022-07-06 5:27 pm | 89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2,816,900 | $3.55 | $9,999,995 | 9,191,119 (Indirect) | View |
2022-06-21 Purchase | 2022-06-23 4:31 pm | AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 302 | $7.99 | $2,413 | 3,748,389 (Indirect) | View |
2022-06-16 Purchase | 2022-06-21 4:33 pm | Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 9,480,052 | $2.15 | $20,382,112 | 24,295,665 (Indirect) | View |
2022-06-13 Purchase | 2022-06-15 4:25 pm | AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 81,424 | $7.951 | $647,402 | 3,748,087 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion